BRASIL, Ministério da Saúde. Orientações sobre o item 8.3 da RDC 48/04 - Anvisa PDFArquivado em 3 de março de 2016, no Wayback Machine.Aces. set. 2015
portal.anvisa.gov.br
ANVISA Listas de Substâncias Uso Proscrito no Brasil (prevista na RESOLUÇÃO DA DIRETORIA COLEGIADA - RDC Nº 39 DE 9 DE JULHO DE 2012) PDFArquivado em 4 de março de 2016, no Wayback Machine. Aces. set. 2015
britannica.com
Encyclopaedia Britannica's editors. Jean-Étienne-Dominique Esquirol / Hallucination. Encyclopaedia Britannica Acesso, Janeiro, 2021]]
JANSEN, K.L.R. (1997) Adverse psychological effects associated with the use of Ecstasy (MDMA) and their treatment. In: Ecstasy Reconsidered (Saunders, N. ed.) pp112-128. Nicholas Saunders, 14 Neal,s Yard, London WC2 9DP, United Kingdom. Ecstasy.org Aces. set 2015
erowid.org
Ungerleider, J. Thomas et al. A Statistical Survey of Adverse Reactions to LSD in Los Angeles County American Journal of Psychiatry Vol 125, Sept 3, 1968, 352-357 Erowid orgAces. set.2015
ispub.com
Z Baysal, M Cengiz, H Oguz, S Ganidagli. Central Anticholinergic Syndrome Induced By Cyclopentolate Eye Drops In A 4 Year Old Child. The Internet Journal of Emergency and Intensive Care Medicine. 2006 Volume 10 Number 1. ISPUB Ace.set. 2015
maps.org
FISHER, Gary. Successful Outcome of a Single LSD Treatment in a Chronically Dysfunctional Man. Bulletin of the Multidisciplinary Association for Psychedelic Studies MAPS - Volume 9 Number 2 Summer 1999 - pp. 11-14 on-line version Aces. set.2015
mdpi.com
Qi J, Zulfiker AHM, Li C, Good D, Wei MQ. The Development of Toad Toxins as Potential Therapeutic Agents. Toxins (Basel). 2018;10(8):336. Published 2018 Aug 20. doi:10.3390/toxins10080336 Disponível em https://www.mdpi.com/2072-6651/10/8/336/htm Aces. agosto de 2019
medscape.com
emedicine.medscape.com
SOYKA M. Alcohol-induced hallucinosis. Clinical aspects, pathophysiology and therapy. Nervenarzt. 1996 Nov. 67(11):891-5. apud: YANG, Zhongshu et al. Alcohol-Related Psychosis. Medscape /Emedicine oct. 2013 Aces. set.2015
Moskowitz, DS; Pinard, Gilbert; Zuroff, David C; Annable, Lawrence; Young, Simon N. The Effect of Tryptophan on Social Interaction in Everyday Life: A Placebo-Controlled Study. Neuropsychopharmacology (2001) 25, 277–289. doi:10.1016/S0893-133X(01)00219-6 PDF Aces. set. 2015
neip.info
Gaujac, Alain. Estudos sobre o psicoativo N,N-dimetiltriptamina (DMT) em Mimosa tenuiflora (Willd.) Poiret e em bebidas consumidas em contexto religioso. Salvador, Ba, Universidade Federal da Bahia Tese Doutorado, Instituto de Química, 2013 Disponível no NEIP Consulta 2015
nih.gov
ncbi.nlm.nih.gov
Nickell P.V.; Uhde T.W. Dose-response effects of intravenous caffeine in normal volunteers.Anxiety. 1994-1995;1(4):161-8. Abstract Aces. set. 2015
Strassman R.J. Adverse reactions to psychedelic drugs. A review of the literature. J Nerv Ment Dis. 1984 Oct;172(10):577-95. Abstract Aces. set 2015
psprings.co.uk
press.psprings.co.uk
RUCKER,James J. H. Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential. BMJ 2015;350:h2902 doi: 10.1136/bmj.h2902 PDFArquivado em 3 de março de 2016, no Wayback Machine. Aces. set. 2015
psychedelic-information-theory.com
KENT, James L. Psychedelic Information Theory Shamanism in the Age of Reason. Seattle, PIT Press / Supermassive, LLC, 2010 ISBN 1453760172PDF Aces. set. 2015
BRASIL, Ministério da Saúde. Orientações sobre o item 8.3 da RDC 48/04 - Anvisa PDFArquivado em 3 de março de 2016, no Wayback Machine.Aces. set. 2015
ANVISA Listas de Substâncias Uso Proscrito no Brasil (prevista na RESOLUÇÃO DA DIRETORIA COLEGIADA - RDC Nº 39 DE 9 DE JULHO DE 2012) PDFArquivado em 4 de março de 2016, no Wayback Machine. Aces. set. 2015
RUCKER,James J. H. Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential. BMJ 2015;350:h2902 doi: 10.1136/bmj.h2902 PDFArquivado em 3 de março de 2016, no Wayback Machine. Aces. set. 2015